Kukje aggressively to enter obese therapeutic markets.

Published: 2006-09-18 06:56:00

Updated: 2006-09-18 06:56:00

Kukje (President: Na Jong-hoon) took a launching ceremony for a new anti-obesity drug at Human Development Board of Korea Oil Pipeline Corporation on Sept. 12, indicating that 4 new drugs for the treatment of obesity be launched into the market. The company already established the same obesity dr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK